Physician profile
Stephen M Solomon
NPI 1982699831
$1,840.13
in general payments reported to CMS, 2019-2025
15 companies · $60.14 in 2025
The $60.14 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $844 · 2021: $14.61 · 2022: $70.46 · 2023: $132 · 2024: $479 · 2025: $60.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $670.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wardlow Enterprises | $795.79 | 2020 | |
| Stryker Corporation | $250.89 | 2024 | Prostep Mica, 7 X 23mm Citrelock Implant, Ortholoc 2 Lapifuse |
| Smith+Nephew, INC. | $207.53 | 2019-2024 | Bone Anchors With Arthroscopic Delivery System, Healicoil, Grafix Pl |
| Treace Medical Concepts, INC. | $169.52 | 2023-2024 | |
| Depuy Synthes Sales INC. | $115.34 | 2020-2023 | Hammerlock |
| Convatec INC. | $99.37 | 2024-2025 | |
| Osiris Therapeutics INC. | $55.23 | 2019 | |
| Prism Medical | $31.60 | 2024 | |
| Linvatec Corporation | $23.64 | 2022 | |
| Organogenesis INC. | $18.14 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $17.50 | 2025 | |
| Medela LLC | $17.44 | 2020 | |
| Integra Lifesciences Corporation | $14.61 | 2021 | |
| Zimmer Biomet Holdings, INC. | $13.46 | 2019 | |
| Kerecis Limited | $10.07 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Solomon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.